<DOC>
	<DOCNO>NCT00496262</DOCNO>
	<brief_summary>This study evaluate single-dose pharmacokinetics human fibrinogen concentrate clot strength ( maximum clot firmness [ MCF ] ) subject congenital fibrinogen deficiency . MCF measure demonstrate functional activity replacement fibrinogen fix dose human fibrinogen concentrate administer .</brief_summary>
	<brief_title>Human Fibrinogen - Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Afibrinogenemia</mesh_term>
	<criteria>Aged â‰¥ 6 year Documented congenital fibrinogen deficiency : fibrinogen deficiency manifest afibrinogenemia plasma fibrinogen activity antigen screen undetectable ( i.e . &lt; 20 mg/dL ) Informed consent sign subject legal guardian Presence history hypersensitivity Human Fibrinogen Concentrate human plasma protein , Presence history deep vein thrombosis , pulmonary embolism , arterial thrombosis Acute bleed History esophageal varicose bleed End stage liver disease ( i.e . ChildPugh score B C ) Planned major surgery need blood transfusion PK blood sample period Polytrauma within 1 year prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Congenital fibrinogen deficiency</keyword>
	<keyword>Fibrinogen concentrate</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Thrombelastography</keyword>
</DOC>